Cardiospheres and tissue engineering for myocardial regeneration: Potential for clinical application

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 5, 2010, Pages 1071-1077

  Gaetani, Roberto ^a,b   Rizzitelli, Giuseppe ^a   Chimenti, Isotta ^a   Barile, Lucio ^c   Forte, Elvira ^a   Ionta, Vittoria ^a   Angelini, Francesco ^a   Sluijter, Joost P G ^b,d   Barbetta, Andrea ^a   Messina, Elisa ^a   Frati, Giacomo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

Cardiac progenitor cells; Cardiac regeneration; Cardiac tissue engineering; Cardiospheres; Cell therapy

Indexed keywords

CYTOLOGY; HEART MUSCLE; HUMAN; METABOLISM; METHODOLOGY; MULTICELLULAR SPHEROID; PHYSIOLOGY; REGENERATION; REVIEW; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; PROCEDURES;

HUMANS; MYOCARDIUM; REGENERATION; SPHEROIDS, CELLULAR; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

EID: 77954748270     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01078.x     Document Type: Review

References (32)

1. Gaetani R, Barile L, Forte E. New perspectives to repair a broken heart. Cardiovasc Hematol Agents Med Chem. 2009, 7:91-107.
2. Zhang M, Methot D, Poppa V. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol. 2001, 33:907-21.
3. Robey TE, Saiget MK, Reinecke H. Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol. 2008, 45:567-81.
4. Zvibel I, Smets F, Soriano H. Anoikis: roadblock to cell transplantation. Cell Transplant. 2002, 11:621-30.
5. Davis ME, Hsieh PC, Takahashi T. Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc Natl Acad Sci USA. 2006, 103:8155-60.
6. Hsieh PC, Davis ME, Gannon J. Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J Clin Invest. 2006, 116:237-48.
7. Padin-Iruegas ME, Misao Y, Davis ME. Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation. 2009, 120:876-87.
8. Muller-Ehmsen J, Krausgrill B, Burst V. Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J Mol Cell Cardiol. 2006, 41:876-84.
9. Hou D, Youssef EA, Brinton TJ. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation 2005, 112:I150-6.
10. Terrovitis J, Lautamaki R, Bonios M. Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. J Am Coll Cardiol. 2009, 54:1619-26.
11. Kutschka I, Chen IY, Kofidis T. Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts. Circulation 2006, 114:I167-73.
12. Martens TP, Godier AF, Parks JJ. Percutaneous cell delivery into the heart using hydrogels polymerizing in situ. Cell Transplant. 2009, 18:297-304.
13. Christman KL, Vardanian AJ, Fang Q. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol. 2004, 44:654-60.
14. Yu J, Christman KL, Chin E. Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy. J Thorac Cardiovasc Surg. 2009, 137:180-7.
15. Huang NF, Yu J, Sievers R. Injectable biopolymers enhance angiogenesis after myocardial infarction. Tissue Eng. 2005, 11:1860-6.
16. Dai W, Wold LE, Dow JS. Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction. J Am Coll Cardiol. 2005, 46:714-9.
17. Landa N, Miller L, Feinberg MS. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation. 2008, 117:1388-96.
18. Hao X, Silva EA, Mansson-Broberg A. Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. Cardiovasc Res. 2007, 75:178-85.
19. Singelyn JM, DeQuach JA, Seif-Naraghi SB. Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering. Biomaterials. 2009, 30:5409-16.
20. Zimmermann WH, Melnychenko I, Wasmeier G. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med. 2006, 12:452-8.
21. Birla RK, Borschel GH, Dennis RG. Myocardial engineering in vivo: formation and characterization of contractile, vascularized three-dimensional cardiac tissue. Tissue Eng. 2005, 11:803-13.
22. Kofidis T, Akhyari P, Wachsmann B. Clinically established hemostatic scaffold (tissue fleece) as biomatrix in tissue- and organ-engineering research. Tissue Eng. 2003, 9:517-23.
23. Cortes-Morichetti M, Frati G, Schussler O. Association between a cell-seeded collagen matrix and cellular cardiomyoplasty for myocardial support and regeneration. Tissue Eng. 2007, 13:2681-7.
24. Chachques JC, Trainini JC, Lago N. Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM clinical trial): one year follow-up. Cell Transplant. 2007, 16:927-34.
25. Schussler O, Coirault C, Louis-Tisserand M. Use of arginine-glycine-aspartic acid adhesion peptides coupled with a new collagen scaffold to engineer a myocardium-like tissue graft. Nat Clin Pract Cardiovasc Med. 2009, 6:240-9.
26. Messina E, De Angelis L, Frati G. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res. 2004, 95:911-21.
27. Barbetta A, Rizzitelli G, Bedini R. Porous gelatin hydrogels by gas-in-liquid foam templating. Soft Matter. 2010, 6:1785-92.
28. Barbetta A, Gumiero A, Pecci R. Gas-in-liquid foam templating as a method for the production of highly porous scaffolds. Biomacromolecules 2009, 10:3188-92.
29. Smith RR, Barile L, Cho HC. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation. 2007, 115:896-908.
30. Chimenti I, Smith RR, Li TS. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res 106:971-80.
31. van Vliet P, Roccio M, Smits AM. Progenitor cells isolated from the human heart: a potential cell source for regenerative therapy. Neth Heart J. 2008, 16:163-9.
32. Smits AM, van Vliet P, Metz CH. Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: an in vitro model for studying human cardiac physiology and pathophysiology. Nat Protoc. 2009, 4:232-43.